Corrêa Flávia M, Migowski Arn, de Almeida Liz M, Soares Marcelo A
Cancer Early Detection Division, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Coordination of Prevention and Surveillance, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Front Med (Lausanne). 2022 Aug 24;9:945621. doi: 10.3389/fmed.2022.945621. eCollection 2022.
As a middle-income country, Brazil has one of the largest public health systems worldwide, which deals with free and universal access to health care. Regarding cervical cancer, the country possesses a large infrastructure for the screening of premalignant and malignant lesions, but yet based on old technology, having Papanicolaou as the major screening method, followed by colposcopy and treatment. Also, large disparities in access are present, which makes effectiveness of screening and treatment in different regions of the country highly unequal. In this review, we describe and evaluate the current screening, treatment and prophylactic (HPV vaccination) strategies to combat cervical cancer in Brazil, and discuss potential incorporation of more recent technologies in these areas in the country to pave its way toward cervical cancer elimination.
作为一个中等收入国家,巴西拥有全球最大的公共卫生系统之一,该系统致力于提供免费且全民可及的医疗保健服务。在宫颈癌方面,该国拥有用于筛查癌前病变和恶性病变的庞大基础设施,但仍基于旧技术,以巴氏涂片作为主要筛查方法,其次是阴道镜检查和治疗。此外,在医疗服务可及性方面存在巨大差异,这使得该国不同地区的筛查和治疗效果极不均衡。在本综述中,我们描述并评估了巴西当前用于抗击宫颈癌的筛查、治疗和预防(HPV疫苗接种)策略,并讨论了在该国这些领域可能采用更新技术以推动其迈向消除宫颈癌目标的情况。